Alex Zhavoronkov
Chief Executive Officer and Chief Business Officer, Insilico Medicine
Alex Zhavoronkov is listed as Chief Executive Officer and Chief Business Officer, Insilico Medicine. B2DB records 2 sessions at 2 conferences between 2024 and 2026, most recently London Tech Week 2026 (June 2026). Speaks mainly on Green Finance & ESG and AI & Data.
Compiled from published conference agendas; not yet confirmed by Alex. Is this you? Claim this profile.
- Topics: Green Finance & ESG, AI & Data
Sessions at 2 conferences
London Tech Week 2026 8 June 2026 – 10 June 2026
- Harder, Better, Faster, Stronger. Panellist · 8 June 2026
World Economic Forum Annual Meeting 2024 15 January 2024 – 19 January 2024
- Open Forum: Turning Back the Clock Panellist · 19 January 2024